Ayala Pharmaceuticals Inc (ADXS)

Currency in USD
0.03470
0.00000(0.00%)
Delayed Data·
ADXS Scorecard
Full Analysis
Stock has taken a big hit over the last week
Earnings results expected in 3 days
Fair Value
Day's Range
0.034700.03470
52 wk Range
0.020000.77700
Key Statistics
Prev. Close
0.0347
Open
0.0347
Day's Range
0.0347-0.0347
52 wk Range
0.02-0.777
Volume
-
Average Volume (3m)
781
1-Year Change
73.5%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADXS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Ayala Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Ayala Pharmaceuticals Inc Company Profile

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company’s lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Compare ADXS to Peers and Sector

Metrics to compare
ADXS
Peers
Sector
Relationship
P/E Ratio
0.0x−3.5x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x10.3x3.3x
Upside (Analyst Target)
0.0%185.6%43.5%
Fair Value Upside
Unlock0.3%6.3%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ADXS Income Statement

FAQ

What Stock Exchange Does Ayala Pharmaceuticals Trade On?

Ayala Pharmaceuticals is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Ayala Pharmaceuticals?

The stock symbol for Ayala Pharmaceuticals is "ADXS."

What Is the Ayala Pharmaceuticals Market Cap?

As of today, Ayala Pharmaceuticals market cap is 1.71M.

What Is Ayala Pharmaceuticals's Earnings Per Share (TTM)?

The Ayala Pharmaceuticals EPS (TTM) is -7.99.

When Is the Next Ayala Pharmaceuticals Earnings Date?

Ayala Pharmaceuticals will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is ADXS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Ayala Pharmaceuticals Stock Split?

Ayala Pharmaceuticals has split 3 times.

How Many Employees Does Ayala Pharmaceuticals Have?

Ayala Pharmaceuticals has 21 employees.

What is the current trading status of Ayala Pharmaceuticals (ADXS)?

As of 05 Aug 2025, Ayala Pharmaceuticals (ADXS) is trading at a price of 0.03, with a previous close of 0.03. The stock has fluctuated within a day range of 0.03 to 0.03, while its 52-week range spans from 0.02 to 0.78.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.